Latest On PRA Health Sciences, Inc (PRAH):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-04-28 20:47 EST | News | PRA Health Sciences EPS beats by $0.02, beats on revenue | N/A |  |
| 2021-04-16 00:43 EST | News | Syneos Health gains following Thermo Fisher $17B deal for PPD | N/A | |
| 2021-04-16 00:42 EST | News | Icon wins U.S. antitrust approval for PRA Health acquisition | N/A | |
| 2021-04-15 06:43 EST | News | PPD gains after report Thermo Fisher nearing $15B deal | N/A | |
| 2021-04-13 18:51 EST | News | PRA Health selected by Maryland State to supply remote patient monitoring services | N/A | |
About PRA Health Sciences, Inc (PRAH):
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phas read more...e I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.
General
- Name PRA Health Sciences, Inc
- Symbol PRAH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 18,100
- Fiscal Year EndDecember
- IPO Date2014-11-13
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://prahs.com
Valuation
- Trailing PE 48.08
- Forward PE 24.75
- Price/Sales (Trailing 12 Mt.) 2.96
- Price/Book (Most Recent Quarter) 6.35
- Enterprise Value Revenue 3.25
- Enterprise Value EBITDA 23.88
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $5.81
- Next Year EPS Estimate $6.60
- Next Quarter EPS Estimate $1.32
- Profit Margin 6%
- Operating Margin 9%
- Return on Assets 5%
- Return on Equity 15%
- Revenue 3.18 billion
- Earnings Per Share $3.04
- Revenue Per Share $50.25
- Gross Profit 1.53 billion
- Quarterly Earnings Growth 9.1%
Highlights
- Market Capitalization 9.43 billion
- EBITDA 415.57 million
- PEG Ratio 1.85
- Analyst Target Price $149.33
- Book Value Per Share $22.92
Share Statistics
- Shares Outstanding 64.54 million
- Shares Float 64.37 million
- % Held by Insiders 24%
- % Held by Institutions 98.91%
- Shares Short 853901
- Shares Short Prior Month 748886
- Short Ratio 1.15
- Short % of Float 2%
- Short % of Shares Outstanding 1%
Technicals
- Beta 1.27
- 52 Week High $150.82
- 52 Week Low $58.67
- 50 Day Moving Average 134.39
- 200 Day Moving Average 118.07
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
PRA Health Sciences, Inc (PRAH) Dividend Calendar:
PRA Health Sciences, Inc (PRAH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
PRA Health Sciences, Inc (PRAH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
PRA Health Sciences, Inc (PRAH) Chart:
PRA Health Sciences, Inc (PRAH) News:
Below you will find a list of latest news for PRA Health Sciences, Inc (PRAH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
PRA Health Sciences, Inc (PRAH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
PRA Health Sciences, Inc (PRAH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-05 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-11-04 | 8-K (Current report) | |
| 2020-09-16 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-09-16 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-16 | 8-K (Current report) | |
| 2020-08-17 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-17 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-17 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-07 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-08-06 | 8-K (Current report) | |
| 2020-06-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-05-26 | S-8 (Securities to be offered to employees in employee benefit plans) | |
| 2020-05-26 | S-8 POS (Securities to be offered to employees in employee benefit plans, post-effective amendments) | |
| 2020-05-22 | 8-K (Current report) | |
| 2020-05-20 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-05-20 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-05-20 | 4 (Statement of changes in beneficial ownership of securities) | |
PRA Health Sciences, Inc (PRAH) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PRA Health Sciences, Inc (PRAH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 24%
Institutional Ownership: 9891%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-09-14 | Glen D. Stettin | Director | Buy | 799.00 | 799.00 | | ||
| 2020-08-13 | Michael J. Bonello | EVP & CFO | Sell | 2,052.00 | 102.88 | 211,109.76 | 21,276.00 | |
| 2020-08-13 | Christopher L Gaenzle | EVP, CAO & General Counsel | Sell | 1,364.00 | 102.88 | 140,328.32 | 37,636.00 | |
| 2020-08-13 | COLIN SHANNON | President & CEO | Sell | 6,073.00 | 102.88 | 624,790.24 | 56,927.00 | |
| 2020-05-18 | Jeffrey T Barber | Director | Buy | 1,324.00 | 14,479.00 | | ||
| 2020-05-18 | JAMES C MOMTAZEE | Director | Buy | 1,748.00 | 3,191.00 | | ||
| 2020-05-18 | Alexander George Dickinson | Director | Buy | 1,324.00 | 5,157.00 | | ||
| 2020-05-18 | Matthew P. Young | Director | Buy | 1,324.00 | 6,877.00 | | ||
| 2020-05-18 | Linda S Grais | Director | Buy | 1,324.00 | 9,433.00 | | ||
| 2020-04-27 | Michael J. Bonello | EVP & CFO | Sell | 3,672.00 | 87.97 | 323,025.84 | 23,328.00 | |
| 2019-09-06 | Fund Holdings L.P. KKR | 10% Share Holder | Sell | 6,666,684.00 | 97.41 | 649,401,688.44 | 29,300.00 | |
| 2019-09-06 | PRA Investors L.P. KKR | 10% Share Holder | Sell | 6,666,684.00 | 97.41 | 649,401,688.44 | 29,300.00 | |
| 2019-08-13 | JAMES C MOMTAZEE | Director | Buy | 1,443.00 | 1,443.00 | | ||
| 2019-08-13 | Michael J. Bonello | EVP & CFO | Buy | 9,000.00 | 27,000.00 | | ||
| 2019-08-13 | COLIN SHANNON | President & CEO | Buy | 33,000.00 | 63,000.00 | | ||
| 2019-06-03 | Jeffrey T Barber | Director | Buy | 1,436.00 | 13,155.00 | | ||
| 2019-06-03 | Alexander George Dickinson | Director | Buy | 1,436.00 | 3,833.00 | | ||
| 2019-06-03 | Matthew P. Young | Director | Buy | 1,436.00 | 5,553.00 | | ||
| 2019-06-03 | Linda S Grais | Director | Buy | 1,436.00 | 8,109.00 | | ||
| 2018-08-16 | COLIN SHANNON | President & CEO | Buy | 30,000.00 | 30,000.00 | |